Trad Alkhelaiwi, country director for Amgen in Saudi Arabia, discusses the intricacies of the Saudi healthcare transformation including the push for a value-based healthcare system that adopts best practices from other healthcare systems, Amgen’s upcoming launch in lung cancer, its plan to invest over USD 80 million in Saudi in the next five years, and how the company is preparing for upcoming cost containment measures.
When it comes to value-based care, Saudi Arabia is still at an early phase, but we are on the right track. We expect the local healthcare system to adopt a more advanced methodology for assessing value
